Update on the epidemiology and diagnosis of invasive fungal infection

International Journal of Antimicrobial Agents

Volumn 32, Issue SUPPL. 2, 2008, Pages

  Cuenca Estrella, Manuel ^a   Bernal Martinez, Leticia ^a   Buitrago, Maria José ^a   Castelli, Maria Victoria ^a   Gomez Lopez, Alicia ^a   Zaragoza, Oscar ^a   Rodriguez Tudela, Juan Luis ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Diagnosis; Epidemiology; Invasive fungal infection

Indexed keywords

AMPHOTERICIN B; BETA 1,3 GLUCAN; ECHINOCANDIN; FLUCONAZOLE; GALACTOMANNAN; ITRACONAZOLE; MANNAN; PIPERACILLIN PLUS TAZOBACTAM; VORICONAZOLE;

ANTIFUNGAL RESISTANCE; ANTIGEN DETECTION; ARTICLE; ASPERGILLOSIS; CANDIDEMIA; CANDIDIASIS; COLORIMETRY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; GRAFT RECIPIENT; HUMAN; MICROBIOLOGICAL EXAMINATION; MORTALITY; MUCORMYCOSIS; MYCELIUM; MYCOSIS; NONHUMAN; NUCLEIC ACID ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

CRITICAL ILLNESS; HUMANS; IMMUNOCOMPROMISED HOST; INCIDENCE; MYCOSES;

EID: 55649119761     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(08)70016-5     Document Type: Article

References (37)

1. Malani A.N., and Kauffman C.A. Changing epidemiology of rare mould infections: implications for therapy. Drugs 67 (2007) 1803-1812
2. Maschmeyer G., Haas A., and Cornely O.A. Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients. Drugs 67 (2007) 1567-1601
3. Osorio J.J., Roman A.R., and Torre-Cisneros J. Spectrum and risk factors of invasive fungal infection [in Spanish]. Enferm Infecc Microbiol Clin 25 (2007) 467-476
4. Caston J.J., Linares M.J., Gallego C., et al. Risk factors for pulmonary Aspergillus terreus infection in patients with positive culture for filamentous fungi. Chest 131 (2007) 230-236
5. Pagano L., Caira M., Nosari A., et al. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study - Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. Clin Infect Dis 45 (2007) 1161-1170
6. Martino R., Subira M., Rovira M., et al. Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients. Br J Haematol 116 (2002) 475-482
7. Upton A., Kirby K.A., Carpenter P., Boeckh M., and Marr K.A. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis 44 (2007) 531-540
8. Gavalda J., Len O., San Juan R., et al. Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study. Clin Infect Dis 41 (2005) 52-59
9. Meersseman W., Lagrou K., Maertens J., and Van Wijngaerden E. Invasive aspergillosis in the intensive care unit. Clin Infect Dis 45 (2007) 205-216
10. Garnacho-Montero J., Amaya-Villar R., Ortiz-Leyba C., et al. Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome. Crit Care 9 (2005) R191-R199
11. Almyroudis N.G., Sutton D.A., Linden P., Rinaldi M.G., Fung J., and Kusne S. Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature. Am J Transplant 6 (2006) 2365-2374
12. Roden M.M., Zaoutis T.E., Buchanan W.L., et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 41 (2005) 634-653
13. Cortez K.J., Roilides E., Quiroz-Telles F., et al. Infections caused by Scedosporium spp. Clin Microbiol Rev 21 (2008) 157-197
14. Nucci M., and Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev 20 (2007) 695-704
15. DiNubile M.J., Lupinacci R.J., Strohmaier K.M., Sable C.A., and Kartsonis N.A. Invasive candidiasis treated in the intensive care unit: observations from a randomized clinical trial. J Crit Care 22 (2007) 237-244
16. Filioti J., Spiroglou K., Panteliadis C.P., and Roilides E. Invasive candidiasis in pediatric intensive care patients: epidemiology, risk factors, management, and outcome. Intensive Care Med 33 (2007) 1272-1283
17. Mean M., Marchetti O., and Calandra T. Bench-to-bedside review: Candida infections in the intensive care unit. Crit Care 12 (2008) 204
18. Wisplinghoff H., Bischoff T., Tallent S.M., Seifert H., Wenzel R.P., and Edmond M.B. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39 (2004) 309-317
19. Almirante B., Rodriguez D., Park B.J., et al. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 43 (2005) 1829-1835
20. Pfaller M.A., and Diekema D.J. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20 (2007) 133-163
21. Dismukes W.E., Pappas P.G., and Sobel J.D. Clinical mycology (2003), Oxford University Press, New York, NY
22. O'Shaughnessy E.M., Shea Y.M., and Witebsky F.G. Laboratory diagnosis of invasive mycoses. Infect Dis Clin North Am 17 (2003) 135-158
23. Richardson M., and Ellis M. Clinical and laboratory diagnosis. Hosp Med 61 (2000) 610-614
24. Gadea I., Cuenca-Estrella M., Martin E., Peman J., Ponton J., and Rodriguez-Tudela J.L. Microbiological procedures for diagnosing mycoses and for antifungal susceptibility testing [in Spanish]. Enferm Infecc Microbiol Clin 25 (2007) 336-340
25. Pfeiffer C.D., Fine J.P., and Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis 42 (2006) 1417-1427
26. Maertens J., Theunissen K., Verbeken E., et al. Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients. Br J Haematol 126 (2004) 852-860
27. Meersseman W., Lagrou K., Maertens J., et al. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med 177 (2008) 27-34
28. Marr K.A., Laverdiere M., Gugel A., and Leisenring W. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin Infect Dis 40 (2005) 1762-1769
29. Mennink-Kersten M.A., Ruegebrink D., Klont R.R., et al. Improved detection of circulating Aspergillus antigen by use of a modified pretreatment procedure. J Clin Microbiol 46 (2008) 1391-1397
30. Odabasi Z., Mattiuzzi G., Estey E., et al. Beta-d-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 39 (2004) 199-205
31. Ostrosky-Zeichner L., Alexander B.D., Kett D.H., et al. Multicenter clinical evaluation of the (1→3) β-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 41 (2005) 654-659
32. Pickering J.W., Sant H.W., Bowles C., Roberts W.L., and Woods G.L. Evaluation of a (17→3)-β-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 43 (2005) 5957-5962
33. Senn L., Robinson J.O., Schmidt S., et al. 1,3-Beta-d-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin Infect Dis 46 (2008) 878-885
34. Ponton J., Moragues M.D., and Quindos G. Non-culture-based diagnostics. In: Calderone R.A. (Ed). Candida and candidiasis (2002), ASM Press, Washington, DC 395-425
35. Sendid B., Caillot D., Baccouch-Humbert B., et al. Contribution of the Platelia Candida-specific antibody and antigen tests to early diagnosis of systemic Candida tropicalis infection in neutropenic adults. J Clin Microbiol 41 (2003) 4551-4558
36. Donnelly J.P. Polymerase chain reaction for diagnosing invasive aspergillosis: getting closer but still a ways to go. Clin Infect Dis 42 (2006) 487-489
37. McMullan R., Metwally L., Coyle P.V., et al. A prospective clinical trial of a real-time polymerase chain reaction assay for the diagnosis of candidemia in nonneutropenic, critically ill adults. Clin Infect Dis 46 (2008) 890-896